REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 63 filers reported holding REPARE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $275 | +82.1% | 22,834 | +59.3% | 0.00% | +200.0% |
| Q2 2023 | $151 | -3.8% | 14,335 | -10.4% | 0.00% | -50.0% |
| Q1 2023 | $157 | -52.6% | 15,994 | -29.0% | 0.00% | -60.0% |
| Q4 2022 | $331 | -99.9% | 22,529 | +86.5% | 0.01% | +66.7% |
| Q2 2021 | $376,000 | -44.3% | 12,083 | -38.6% | 0.00% | -78.6% |
| Q4 2020 | $675,000 | – | 19,683 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $32,989,176 | 13.80% |
| CHI Advisors LLC | 2,800,126 | $41,189,854 | 10.97% |
| MPM BioImpact LLC | 1,639,849 | $24,122,179 | 6.26% |
| BVF INC/IL | 8,291,988 | $121,975,143 | 5.15% |
| Deep Track Capital, LP | 2,727,606 | $40,123,084 | 1.68% |
| Redmile Group, LLC | 2,684,396 | $39,487,465 | 1.62% |
| HighVista Strategies LLC | 164,890 | $2,425,532 | 1.44% |
| Orbimed Advisors | 3,322,488 | $48,873,798 | 0.94% |
| Artal Group S.A. | 700,000 | $10,297 | 0.58% |
| HARBOR CAPITAL ADVISORS, INC. | 34,572 | $508,554 | 0.49% |